{主关键词}

一 | Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。

二 |

三 | 如中超联赛第二阶段赛事按原计划于7月21日至8月21日进行,上述5人以及其他作为俱乐部主力的国脚将受各类客观因素影响缺席多轮中超比赛。此外,效力于山东泰山俱乐部的韩国籍外援孙准浩近期也已接到韩国队参加东亚杯的征调通知。这样看来,中超联赛第二阶段如延期开赛,将一定程度上缓解国脚输送俱乐部的用人危机,有益于联赛公平竞争的维护。毕竟在参加完东亚杯赛,回国并按防疫规定接受必要医学隔离观察后,球员们最快可在8月上旬重返各俱乐部队。欲加速推动恢复主客场制 不过,配合国足备战、参加东亚杯只是考虑调整联赛赛程的部分原因。

四 | 正如北青报记者此前了解到的,中超联赛主办方结合国家及相关各地方防疫政策的调整,并综合考虑俱乐部及其属地、赞助商、球迷意愿等因素,欲加速推动中超联赛主客场制的恢复工作,并已着手拟定相关计划用以向体育管理及相关部门申报。据悉,赛事主办方拟安排中超联赛第二阶段延后开赛的主要原因,正是为落实联赛主客场恢复各项准备工作而预留时间。众所周知,联赛一旦恢复主客场制,那么防疫工作依然是首当其冲的重任,办赛须满足赛区所在地的各项防疫工作要求。此外,办赛还须满足训练与比赛场地条件、赛区接待能力、安保工作、赛区间交通条件。例如,部分俱乐部队原主场场地受疫情影响近几年连续无缘承办足球赛事,其草皮及场馆其他设施需要经过整改才能满足联赛办赛条件。一旦条件不达标,那么还须落实备选场地。由此可见,联赛欲恢复主客场制,不仅需要行业管理部门协同各有关部门支持,还需要俱乐部属地的全力支持。此外,赛事一旦恢复主客场制,那么各俱乐部无论主场作战,还是做客比赛,都需要承担相当的参赛成本。

五 | 比如主队接待与赛事安保费用,客队城际间交通费用、赴客场后的食宿及交通费用等。在当下大部分俱乐部面临运营压力的背景下,这些问题都需要各方通盘考虑,并做出合理的应对方案。具体工作落实需要足够时间 联赛赛制一旦变更还涉及一系列其他问题。原计划承办赛会制比赛的各赛区也要根据最终确认的竞赛计划来推出应对举措。

六 | 举例来说,为配合中超联赛赛会制赛事的举办,梅州、海口、大连3个赛区前期做了很多工作,付出了巨大的人力、物力、财力。

七 | 为了做好各队接待工作,赛区内驻地酒店均特意为参赛人员预留了足够的房源及客房档期。如果赛制调整,酒店方也需要及时调整接待方案,从而竭力避免经济损失。

八 | 联赛恢复主客场制是联赛参与者、组织与管理者、球迷、赞助商各方众望所盼,但赛制调整,特别是赛季中的调整带来的问题多样,需要协调处理的工作庞杂,因此客观上也需要足够的时间加以落实。需要说明的是,一旦中超联赛第二阶段赛事确认延至8月上旬(初步计划于8月6日)开赛,那么留给余下轮次赛事完赛的时间同样紧张,整个赛季落幕时间相应延后也都不可避免。具体落幕时间可能要延至12月,也就是卡塔尔世界杯进行期间或之后。文/本报记者 肖赧

九 |
Current article:http://www.shangfochengcongshuaizhuang.buzz/z05a/iwfwp.html
Published on:16:06:42
我的网站热门国内